Uri Lopatin Net Worth (Estimated)

Who is Uri Lopatin?

Uri Lopatin is a serial biotech entrepreneur and infectious disease physician, known for founding Pardes Biosciences (S20 YC) to develop oral antivirals. He previously co-founded Assembly Biosciences and held leadership roles at several major pharmaceutical companies.

Highlights:

• Y Combinator S20 alum and founder of Pardes Biosciences.
• Co-founded Assembly Biosciences and helped raise over $300 million for hepatitis
• Held clinical and translational science roles at Schering-Plough, Roche, and Gil

About Pardes Biosciences

We make oral drugs to treat and prevent viral infections - like COVID-19.

Model inputs

• Stage: public
• Valuation tier: fallback-public
• Valuation note: Clear leftover $51.6M tracker/Form D. Do not invent a $52M lock, SPAC proceeds as a priced round, or an acquisition enterprise value.
• Research as-of: 2026-09-14
• Funding source: https://www.globenewswire.com/news-release/2021/12/27/2358007/0/en/pardes-biosciences-debuts-as-a-publicly-traded-company-focused-on-oral-antiviral-therapies-to-potentially-treat-and-prevent-covid-19.html

FAQ: Uri Lopatin net worth and Pardes Biosciences valuation

What is Uri Lopatin's net worth?

Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.

Uri Lopatin net worth

Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. This Uri Lopatin net worth figure is estimated paper wealth, not a verified statement of assets.

How much is Uri Lopatin worth?

Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. How much Uri Lopatin is worth here means estimated paper wealth from public company and role data — not financial advice.

How rich is Uri Lopatin?

Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. “How rich is Uri Lopatin” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.

Uri Lopatin fortune

Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. This Uri Lopatin fortune figure is estimated paper wealth only, not a verified statement of assets.

Uri Lopatin equity value

Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. Uri Lopatin equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.

What is Pardes Biosciences valuation?

Pardes Biosciences's estimated valuation on Entrepreneurial Check is $2.0B. Independent model output, not a verified appraisal or official mark.

What is Pardes Biosciences post-money valuation?

Pardes Biosciences's estimated valuation on Entrepreneurial Check is $2.0B. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.

What is Pardes Biosciences CEO net worth?

Uri Lopatin is listed as CEO at Pardes Biosciences. Uri Lopatin's estimated net worth / paper wealth is $150.0M (range $105.0M–$225.0M) as of 2026. This Pardes Biosciences CEO net worth figure is an independent paper-wealth estimate, not verified net worth.

What is Pardes Biosciences funding?

Pardes Biosciences funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Pardes Biosciences raised is not a complete cap table — figures are estimates only.

How much did Pardes Biosciences raise?

How much Pardes Biosciences raised, when disclosed, informs the estimated Pardes Biosciences valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.

How much money did Pardes Biosciences raise?

How much money Pardes Biosciences raised, when a public figure is available, is a model input for the estimated Pardes Biosciences valuation on this profile. Estimates only — not a complete cap table.

What is Pardes Biosciences series funding?

Pardes Biosciences series funding, when a public raise is disclosed, informs the estimated Pardes Biosciences valuation here. Not a complete financing history.

What company is Uri Lopatin building?

Uri Lopatin is CEO at Pardes Biosciences, a Y Combinator-backed startup (batch S20).

What does Pardes Biosciences do?

Pardes Biosciences — We break viruses

What YC batch is Uri Lopatin from?

Uri Lopatin is associated with Y Combinator batch S20.

Where did Uri Lopatin go to school?

Public profiles associate Uri Lopatin with MD from University of Medicine and Dentistry of NJ – NJ Medical School; Bachelor's degree cum laude in biology from Cornell University; Internal Medicine training at UMDNJ-New Jersey Medical School, University of Washing.

What other companies is Uri Lopatin connected to?

Public associations for Uri Lopatin include Assembly Pharmaceuticals, Assembly Biosciences, Schering-Plough, Roche.

Where is Uri Lopatin based?

Public directory data lists Uri Lopatin's region as United States of America.

What industry is Uri Lopatin in?

Uri Lopatin is listed under Healthcare, Drug Discovery and Delivery.

How big is Pardes Biosciences?

Public data lists Pardes Biosciences's team size as 2.

What is Pardes Biosciences's status?

Pardes Biosciences is listed as Public in public company data.

What else is notable about Uri Lopatin?

Co-founded Assembly Biosciences and helped raise over $300 million for hepatitis.

Is Entrepreneurial Check affiliated with Y Combinator?

No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.